SPRY — ARS PHARMACEUTICALS INC
As of Q2 2026, 32 SEC-registered investment managers reported holding SPRY (ARS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $160.53M across 20.07M shares. That is -23.1% by share count (-6.01M shares) versus the previous quarter, while reported value moved -23.2%. Ownership is concentrated: the five largest holders account for 71.0% of reported value and the top ten for 86.6%.
Compared with the prior quarter, 5 opened new positions, 17 added to existing stakes, 6 trimmed, 4 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SPRY is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 5.31M | $42.54M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 3.51M | $40.88M | 0.00% | Hold |
| Franklin Resources history | Q1 2026 | 3.28M | $26.33M | 0.01% | Add |
| Wellington Management Group history | Q2 2025 | 1.43M | $25.01M | 0.01% | Add |
| Capital World Investors history | Q2 2026 | 2.75M | $22.07M | 0.00% | New |
| Millennium Management history | Q2 2026 | 2.52M | $20.19M | 0.01% | Reduce |
| Casdin Capital history | Q4 2025 | 1.60M | $18.64M | 1.16% | Hold |
| UBS Group AG history | Q2 2026 | 1.94M | $15.54M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.70M | $13.61M | 0.00% | Add |
| Baron Funds history | Q1 2026 | 1.27M | $10.22M | 0.03% | Hold |
| Third Point history | Q2 2026 | 1.00M | $8.01M | 0.19% | Hold |
| Citadel Advisors history | Q2 2026 | 566.56K | $4.54M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 551.42K | $4.42M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 549.06K | $4.40M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 463.26K | $3.71M | 0.00% | Add |
| Fidelity International (FIL) history | Q2 2026 | 455.57K | $3.65M | 0.00% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 363.32K | $3.11M | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 380.77K | $3.05M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 349.16K | $2.80M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 229.10K | $1.84M | 0.00% | Reduce |
New Positions (Q2 2026)
- Capital World Investors 2.75M sh · $22.07M
- JPMorgan Chase & Co 363.32K sh · $3.11M
- Two Sigma Investments 52.40K sh · $419.72K
- Principal Global Investors 29.73K sh · $238.11K
- Prudential Financial 10.04K sh · $80.46K
Fully Exited (vs previous quarter)
- Franklin Resources sold 3.28M sh · $26.33M
- Baron Funds sold 1.27M sh · $10.22M
- Janus Henderson Group sold 21.60K sh · $173.56K
- D. E. Shaw & Co sold 11.87K sh · $95.34K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 4.25M | 4.57M | 4.30M | 4.42M | 4.83M | 5.09M | 5.01M | 5.31M |
| Capital World Investors | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.75M |
| Millennium Management | 953.69K | 595.26K | — | 455.05K | 349.28K | 31.70K | 249.41K | 1.27M | 1.15M | — | — | — | 486.75K | 939.28K | 807.04K | 878.16K | — | 3.17M | 5.98M | 2.52M |
| UBS Group AG | 13.73K | 78.84K | 513 | 502 | 12 | — | 2.90K | — | — | 1.73K | 104.44K | 64.92K | 109.88K | 1.01M | 591.18K | 866.93K | 659.89K | 2.21M | 2.26M | 1.94M |
| Geode Capital Management | 185.11K | 392.11K | 362.64K | 223.65K | 224.38K | 332.20K | 403.60K | 653.60K | 803.34K | 864.87K | 876.67K | 1.20M | 1.23M | 1.24M | 1.26M | 1.34M | 1.51M | 1.55M | 1.53M | 1.70M |
| Third Point | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 556.24K | 1.00M | 1.00M |
| Citadel Advisors | 74.49K | 93.56K | 195.16K | 380.97K | 109.67K | 47.90K | 84.58K | 283.55K | 176.24K | 118.50K | 179.26K | 161.06K | 416.30K | 1.05M | 972.79K | 2.36M | 1.73M | 2.04M | 1.84M | 566.56K |
| Charles Schwab Investment Management | 139.10K | 148.94K | 147.38K | 106.41K | — | 16.17K | 16.17K | 71.61K | 324.40K | 329.55K | 345.30K | 415.53K | 423.95K | 427.48K | 416.66K | 442.20K | 520.76K | 550.93K | 533.39K | 551.42K |
| Northern Trust Corp | 185.75K | 179.86K | 173.57K | 37.26K | 39.28K | 67.30K | 71.97K | 230.69K | 261.14K | 259.68K | 262.11K | 267.57K | 452.38K | 478.15K | 487.04K | 485.01K | 531.50K | 521.01K | 529.28K | 549.06K |
| Bank of America Corp | 3.29K | 23.78K | 263.87K | 243.44K | 10.45K | 13.24K | 24.50K | 26.43K | 56.44K | 98.60K | 81.58K | 108.07K | 179.86K | 160.96K | 444.70K | 325.35K | 272.03K | 482.08K | 285.73K | 463.26K |
| Fidelity International (FIL) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 810.07K | 455.57K | 455.57K |
| JPMorgan Chase & Co | 49.65K | 171.82K | 13.76K | 1.50K | 2.11K | 2.57K | 3.32K | 28.13K | 39.88K | 81.55K | 50.18K | 33.00K | 130.70K | 31.11K | 32.20K | 34.56K | 35.06K | 417.09K | — | 363.32K |
| Goldman Sachs Group | 54.35K | 78.23K | 101.69K | 123.29K | 99.65K | 112.89K | 196.50K | 123.15K | 239.45K | 141.10K | 462.72K | 440.74K | 275.86K | 886.12K | 717.95K | 1.46M | 1.33M | 812.04K | 724.22K | 380.77K |
| Fidelity Management & Research (FMR) | 4.29M | 3.75M | 3.79M | 3.72M | 4.76M | 5.37M | 5.09M | 4.66M | 1.31M | 1.20M | 1.08M | 1.09M | 1.09M | 1.10M | 990.86K | 1.57M | 742.51K | 398.96K | 342.04K | 349.16K |
| Morgan Stanley | 638.70K | 1.39M | 385.95K | 237.61K | 56.09K | 89.21K | 99.61K | 60.68K | 84.21K | 107.91K | 97.95K | 133.81K | 638.62K | 432.60K | 442.51K | 383.62K | 700.41K | 552.36K | 316.67K | 229.10K |
| BNY Mellon | 56.67K | 60.06K | 58.64K | — | — | 15.19K | 15.19K | 76.90K | 83.92K | 84.36K | 69.89K | 139.28K | 131.61K | 130.24K | 132.21K | 145.12K | 154.60K | 163.01K | 164.06K | 168.14K |
| Marshall Wace | 275.57K | — | — | — | — | 32.01K | 39.43K | 74.62K | — | — | — | — | 77.88K | 52.91K | 156.63K | 39.91K | 197.32K | 79.21K | 105.01K | 123.71K |
| Citigroup Inc | 2.53K | 7.25K | 5.68K | 740 | 418 | 95.01K | 53.38K | 19.97K | 1.77K | 5.24K | 97.46K | 26.42K | 37.22K | 100.68K | 95.21K | 37.58K | 8.62K | 18.56K | 18.62K | 89.20K |
| Deutsche Bank AG | 11.80K | 12.46K | 11.14K | — | — | — | — | — | — | 15.25K | 14.74K | 20.79K | 28.77K | 43.38K | 39.10K | 37.01K | 41.95K | 48.73K | 54.49K | 65.87K |
| Balyasny Asset Management | — | — | — | — | — | 11.33K | — | — | — | 17.44K | 30.44K | 26.34K | 22.52K | 344.94K | 171.12K | 329.07K | 246.17K | — | 61.75K | 64.66K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details